unknown
Stage
About
ImmunoVec develops in vivo therapies to precisely engineer targeted cell types within the human body using cell type- and state-specific transcriptional control elements applicable across viral and non-viral delivery platforms.
Explore ImmunoVec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.